Premium
Changes in antioxidant, inflammatory and metabolic markers during 1 week cultivation of human skin explants
Author(s) -
Vostálová Jitka,
Galandáková Adéla,
Zálešák Bohumil,
Lichnovská Radka,
Čížková Kateřina,
Ulrichová Jitka,
Rajnochová Svobodová Alena
Publication year - 2019
Publication title -
journal of applied toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.784
H-Index - 87
eISSN - 1099-1263
pISSN - 0260-437X
DOI - 10.1002/jat.3766
Subject(s) - glutathione reductase , glutathione , superoxide dismutase , glutathione peroxidase , antioxidant , lipid peroxidation , catalase , oxidative stress , chemistry , biochemistry , pharmacology , biology , enzyme
Abstract Human skin explant (HSE) seems to be a useful model for dermatological/cosmetic testing. HSE prepared from donor superfluous skin from plastic surgery operations is cheap and easily obtainable compared to reconstructed models. The HSE use, however, may be limited by the degeneration processes during cultivation. The aim was to monitor changes in metabolic activity and selected apoptotic, inflammatory and antioxidant parameters during 7 day cultivation. The significant changes were found in the superoxide dismutase‐2 level from day 5, glutathione S ‐reductase level from day 6, metabolic activity and fibulin‐5 level from day 4, cyclooxygenase‐2, interleukin‐6 and interleukin‐10 from day 1 to 2. Other selected markers (lipid peroxidation products and glutathione level, glutathione S ‐transferase, catalase, superoxide dismutase and glutathione S ‐reductase activity, glutathione peroxidase and glutathione S ‐reductase levels) were not modified significantly due to high inter‐individual variability of skin donors. The HSE microstructure as well as cytokeratin‐10 and proliferation marker Ki67 expression was also only minimally affected during cultivation. Collectively, the results demonstrate that HSE represents a good model for short‐term studies focused on the physical and chemical agent toxicity, protective potential of compounds or metabolic biotransformation. However, reduced metabolic activity, increased inflammation and the high inter‐individual variability and sensitivity of donors have to be taken into consideration.